Illumina is engaged in sequencing- and array-based solutions for genetic and genomic analysis. The company's products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. The company's portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed to accelerate and simplify genetic analysis.Co.'s portfolio of sequencing platforms represents a family of systems that are used by customers to perform whole-genome, de novo, exome and ribonucleic acid sequencing, and targeted resequencing of specific gene regions and genes.
- TickerILMN
- ISINUS4523271090
- ExchangeNASDAQ Stock Market
- SectorPharmaceuticals & Biotechnology
- CountryUnited States
Access reports individually or via Subscription
Receive monthly invoices with payment via CSA or hard dollars
Analyst access
Free Trial Subscriptions
Team account with shared subscriptions
Advanced analytics to track research consumption and performance
